ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

November 11, 1977

Particle Radiation Working Group Asks Support For Facilities, Trials

June 23, 1978

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995